Weight gain and antidepressants
M Fava - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …
who have weight loss as a symptom of depression or a residual symptom in patients who …
[HTML][HTML] Estimating risk of antidepressant withdrawal from a review of published data
MA Horowitz, A Framer, MP Hengartner, A Sørensen… - CNS drugs, 2023 - Springer
Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The
outcome of adaptation is often referred to as 'physical dependence'in pharmacology, as …
outcome of adaptation is often referred to as 'physical dependence'in pharmacology, as …
Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression
ZV Segal, P Bieling, T Young… - Archives of general …, 2010 - jamanetwork.com
Context Mindfulness-based cognitive therapy (MBCT) is a group-based psychosocial
intervention designed to enhance self-management of prodromal symptoms associated with …
intervention designed to enhance self-management of prodromal symptoms associated with …
Serotonin and norepinephrine reuptake inhibitors
RC Shelton - Antidepressants: From Biogenic Amines to New …, 2019 - Springer
This chapter covers antidepressants that fall into the class of serotonin (5-HT) and
norepinephrine (NE) reuptake inhibitors. That is, they bind to the 5-HT and NE transporters …
norepinephrine (NE) reuptake inhibitors. That is, they bind to the 5-HT and NE transporters …
Antidepressant discontinuation syndromes: clinical relevance, prevention and management
PM Haddad - Drug Safety, 2001 - Springer
Discontinuation symptoms are recognised with tricyclic antidepressants, monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs) and miscellaneous …
oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs) and miscellaneous …
[HTML][HTML] Antidepressant discontinuation syndrome
CH Warner, W Bobo, C Warner, S Reid… - American family …, 2006 - aafp.org
Antidepressant Discontinuation Syndrome | AAFP Advertisement search close brand logo
CHRISTOPHER H. WARNER, MAJ, MC, USA, WILLIAM BOBO, LCDR, MC, USN …
CHRISTOPHER H. WARNER, MAJ, MC, USA, WILLIAM BOBO, LCDR, MC, USN …
Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.
OBJECTIVE: To assess the consequences to mother and baby of abruptly discontinuing
antidepressant or benzodiazepine medication during pregnancy and to assess the impact of …
antidepressant or benzodiazepine medication during pregnancy and to assess the impact of …
Principles of laboratory assessment of drug abuse liability and implications for clinical development
LP Carter, RR Griffiths - Drug and Alcohol dependence, 2009 - Elsevier
Abuse liability testing plays an important role in informing drug development, regulatory
processes, and clinical practice. This paper describes the current “gold standard” …
processes, and clinical practice. This paper describes the current “gold standard” …
[图书][B] Your drug may be your problem: How and why to stop taking psychiatric medications
P Breggin, D Cohen - 2007 - books.google.com
When first published in 1999, Your Drug May Be Your Problem was ahead of its time. The
only book to provide an uncensored description of the dangers involved in taking every kind …
only book to provide an uncensored description of the dangers involved in taking every kind …
Evaluation of pain in the critically ill patient
RJ Hamill-Ruth, ML Marohn - Critical care clinics, 1999 - Elsevier
Pain is common in almost every age group; therefore, it can be expected to be seen in the
intensive care unit (ICU) patient as a pre-existing complaint. The pain may be a result of the …
intensive care unit (ICU) patient as a pre-existing complaint. The pain may be a result of the …